News

Parmax Pharma reports standalone net profit of Rs 0.17 crore in the September 2026 quarter

17-Nov-2026 | 07:40
Sales rise 362.45% to Rs 11.70 crore
Net profit of Parmax Pharma reported to Rs 0.17 crore in the quarter ended September 2026 as against net loss of Rs 2.08 crore during the previous quarter ended September 2025. Sales rose 362.45% to Rs 11.70 crore in the quarter ended September 2026 as against Rs 2.53 crore during the previous quarter ended September 2025.

ParticularsQuarter Ended
Sep. 2026Sep. 2025% Var.
Sales11.702.53 362
OPM %-11.62-62.85 -
PBDT0.66-1.82 LP
PBT0.17-2.08 LP
NP0.17-2.08 LP

Powered by Capital Market - Live News